NEW YORK, June 23, 2018 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of ADT Inc. (NYSE: ADT) pursuant and/or traceable to the registration statement and prospectus (the...
ADT NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against ADT Inc. - ADT
↧
↧
Fractyl Announces Presentation of Key Scientific Research at ADA 2018 Indicating That Modern Diets Durably Alter Duodenal Lining, Highlighting the Intestine's Role in Type 2 Diabetes and NASH
LEXINGTON, Mass. and ORLANDO, Fla., June 23, 2018 /PRNewswire/ -- Fractyl Laboratories Inc. (Fractyl) today announced the presentation of breakthrough research providing the first clear mechanistic link between modern diets and their causal effect on the pandemics of insulin resistance, ob...
↧
Real-World Evidence Shows Oral INVOKANA® (canagliflozin) Results in Greater Weight Loss and Treatment Adherence Than Injectable GLP-1 Receptor Agonists in Type 2 Diabetes Patients
TITUSVILLE, N.J. and ORLANDO, Fla., June 23, 2018 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new findings from two real-world studies comparing sodium glucose co-transporter-2 inhibitor (SGLT2i) INVOKANA® (canagliflozin) and glucagon-like...
↧
One Third of Participants in a Workforce Study Reduce Risk for Diabetes after Employer Wellness Screening and Behavioral Counseling, Finds Quest Diagnostics Study
SECAUCUS, N.J. and ORLANDO, Fla., June 23, 2018 /PRNewswire/ -- Employer wellness programs that combine laboratory and biometric screening with digital behavioral counseling can significantly reduce employees' risk of developing chronic conditions such as diabetes and cardiovascular...
↧
Oral semaglutide demonstrated significant reduction in blood sugar vs placebo in PIONEER 1 trial
ORLANDO, Fla., June 23, 2018 /PRNewswire/ -- Oral semaglutide, an investigational GLP-1 receptor agonist taken as a once-daily tablet, achieved significant reductions in blood sugar versus placebo in adults with type 2 diabetes, according to findings from the PIONEER 1 phase 3a trial. The...
↧
↧
Ozempic® provided greater weight reductions for adults with a baseline BMI ≥25kg/m2 than those with lower baseline BMI
ORLANDO, Fla., June 23, 2018 /PRNewswire/ -- Ozempic® (semaglutide) injection 0.5 mg or 1 mg provided greater weight reductions vs dulaglutide 0.75 mg or 1.5 mg, respectively, in adults with type 2 diabetes, regardless of baseline body mass index (BMI), with the greatest reductions...
↧
Los módulos de alta eficiencia de GCL System Integration expuestos en Intersolar
MÚNICH, 23 de junio de 2018 /PRNewswire/ -- GCL System Integration (SZ: 002506) (GCL-SI), una filial de GCL Group, el conglomerado mundial líder en energía limpia, expone actualmente su última serie de módulos 300W+ de altísima eficiencia (de más de 300 W) en Intersolar 2018, con los que...
↧
Press statement from the Dr. Richard Izquierdo Health and Science Charter School about Lesandro Guzman-Feliz
BRONX, N.Y., June 23, 2018 /PRNewswire/ -- The board of trustees, faculty, staff and students of the Dr. Richard Izquierdo Health and Science Charter School are heartbroken at the loss of our student, friend and classmate Lesandro (Junior) Guzman-Feliz. Lesandro was a sophomore at our scho...
↧
GCL System Integration stellt hocheffiziente Module auf Intersolar aus
MÜNCHEN, 23. Juni 2018 /PRNewswire/ -- GCL System Integration (SZ: 002506) (GCL-SI), ein Tochterunternehmen des weltweit führenden Clean-Energy-Konzerns GCL Group, stellt seine neuesten ultraeffizienten 300W+ Series Module auf der Intersolar 2018 aus. Dadurch untermauert das Unternehmen...
↧
↧
Declaración de prensa de la escuela Dr. Richard Izquierdo Health and Science Charter School sobre Lesandro Guzman-Feliz
BRONX, Nueva York, 23 de junio de 2018 /PRNewswire-HISPANIC PR WIRE/ -- El consejo de administración, el cuerpo docente, el personal administrativo y el alumnado de la escuela Dr. Richard Izquierdo Health and Science Charter School desean expresar su dolor ante la sensible pérdida de...
↧
Alcohol Justice and CAPA: Blockbuster Reports Destroy Arguments to Extend California Last Call to 4 a.m.
SACRAMENTO, Calif., June 23, 2018 /PRNewswire-USNewswire/ -- At a press event on the Capitol steps last week, California Alcohol Policy Alliance (CAPA) and Alcohol Justice released two new reports on the statewide public health and safety threats of extending alcohol sales to 4...
↧
Newby Teas Contain Least Amount of Fluoride per Cup, Independent Study by Eurofins Lab Reveals
DUBAI, UAE, June 24, 2018 /PRNewswire/ --
Laboratory Testing on a Wide Range of Premium Tea Brands Revealed Dangerous High Levels of Fluoride
Newby Teas, predominantly owned by a British registered charity, conducted an independent study to test their own product and to enlighten t...
↧
Sport Integrity Hotline Receives More Than 50 Allegations of Misconduct in First Six Months
DOHA, Qatar, June 24, 2018 /PRNewswire/ --
The Sport Integrity Hotline, launched in December 2017 to address the growing issues confronting the sport industry, has already received over 50 allegations of wrongdoing in sport, originating from 10 different regions and over 20 countries...
↧
↧
Thermo Fisher Scientific Donates Rapid DNA Analysis Technology to Help Reunite Families Recently Separated at Border
WALTHAM, Mass., June 24, 2018 /PRNewswire/ -- Thermo Fisher Scientific, the world leader in serving science, today announced it is offering to donate $1 million worth of rapid DNA analyzers and related technology to support efforts to reunite children and parents recently separated at...
↧
Adding Liraglutide to Insulin Regimen for People with Type 1 Diabetes Improved Glycemic Control
ORLANDO, Fla., June 24, 2018 /PRNewswire-USNewswire/ -- Adults with type 1 diabetes (T1D) who take a daily dose of liraglutide demonstrated improvements in HbA1c levels, weekly average blood glucose levels and increased weight loss, according to the study, "Liraglutide as an Additional...
↧
University of New Hampshire Selects Ex Libris Alma and Primo
CHICAGO, June 24, 2018 /PRNewswire/ -- Ex Libris®, a ProQuest company, is pleased to announce that the University of New Hampshire (UNH) has chosen the Ex Libris Alma® library services platform and Ex Libris Primo® discovery and delivery solution. The UNH Library is the 11th member of the...
↧
Real-World Data Show Advantages in People Treated with Lilly's Once-Weekly Trulicity® (dulaglutide) Compared to Those Treated with Liraglutide and Exenatide QW
INDIANAPOLIS, June 24, 2018 /PRNewswire/ -- People with type 2 diabetes new to treatment with a glucagon-like peptide-1 (GLP-1) receptor agonist (RA) had better blood sugar control, were more likely to adhere to treatment and stayed on treatment longer with once-weekly Trulicity®...
↧
↧
AJC: Presbyterians Continue with BDS, Reject Curtailing Dialogue with Israel Supporters
NEW YORK, June 24, 2018 /PRNewswire-USNewswire/ -- AJC regrets that the Presbyterian Church (U.S.A.), at its biennial General Assembly (GA), reaffirmed its support for BDS by adopting a measure opposing anti-BDS legislation.
"The Church remains obsessively critical of Israel in its...
↧
MIM Software Inc. se asocia con Spectrum Dynamics Medical
CLEVELAND, 24 de junio de 2018 /PRNewswire/ -- MIM Software Inc., un proveedor mundial líder en software de imagenología médica y medicina nuclear, ha anunciado hoy su asociación con Spectrum Dynamics Medical (Israel) para proporcionarle MIM-SD, un avanzado software de procesamiento...
↧
MIM Software Inc. schließt sich mit Spectrum Dynamics Medical zusammen
CLEVELAND, 24. Juni 2018 /PRNewswire/ -- MIM Software Inc., ein weltweit führender Anbieter von Software für bildgebende Diagnostik und Nuklearmedizin, gab heute bekannt, dass es sich mit Spectrum Dynamics Medical (Israel) zusammengeschlossen hat, um MIM-SD, eine hochentwickelte...
↧
More Pages to Explore .....
